as 12-20-2024 4:00pm EST
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.
Founded: | 1998 | Country: | United States |
Employees: | N/A | City: | REDWOOD CITY |
Market Cap: | 5.9B | IPO Year: | N/A |
Target Price: | $75.25 | AVG Volume (30 days): | 908.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.26 | EPS Growth: | 57.97 |
52 Week Low/High: | $20.84 - $62.22 | Next Earning Date: | 02-13-2025 |
Revenue: | $628,555,000 | Revenue Growth: | 39.67% |
Revenue Growth (this year): | 46.29% | Revenue Growth (next year): | 17.09% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Swisher Daniel N JR | CORT | Director | Dec 10 '24 | Sell | $59.46 | 2,200 | $130,812.00 | 0 | |
Robb Gary Charles | CORT | Chief Business Officer | Nov 22 '24 | Sell | $56.20 | 2,609 | $146,625.80 | 20,163 | |
Lyon Joseph Douglas | CORT | See Remarks | Nov 22 '24 | Sell | $56.72 | 1,411 | $80,031.92 | 8,494 | |
Swisher Daniel N JR | CORT | Director | Nov 11 '24 | Sell | $59.88 | 2,200 | $131,736.00 | 0 | |
Guyer William | CORT | Chief Development Officer | Nov 1 '24 | Sell | $48.97 | 10,000 | $489,700.00 | 5,796 | |
Guyer William | CORT | Chief Development Officer | Oct 1 '24 | Sell | $46.28 | 10,000 | $462,800.00 | 5,796 | |
Robb Gary Charles | CORT | Chief Business Officer | Sep 27 '24 | Sell | $46.28 | 11,000 | $509,080.00 | 20,163 |
CORT Breaking Stock News: Dive into CORT Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
Clinical Trials Arena
5 days ago
MT Newswires
6 days ago
Business Wire
6 days ago
Benzinga
9 days ago
MT Newswires
9 days ago
Business Wire
9 days ago
Zacks
10 days ago
The information presented on this page, "CORT Corcept Therapeutics Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.